Avalanche Energy hits key milestone on the road to a desktop fusion reactor

Avalanche Energy successfully operated its desktop fusion machine at 300,000 volts for hours, a critical milestone the company believes will enable net energy gain in its small-scale fusion reactors. This achievement, leveraging a unique high-voltage design, underpins their strategy to generate revenue from radioisotope sales and the new Washington State-funded FusionWERX testing facility, projecting profitability by 2028 and $30-50 million in revenue by 2029. The company is reportedly raising a Series A round to fulfill the required cost-match for the $10 million state grant.

Analysis

Avalanche Energy, a private fusion startup, has achieved a significant technical milestone by operating its desktop fusion machine at 300,000 volts for sustained periods. This achievement is critical as the company posits this voltage level is sufficient to enable a reactor that produces more energy than it consumes. The company's technology is distinct within the fusion sector, utilizing intense electrical currents and targeting a density of 6 million volts per meter, rather than the more common magnetic confinement approach. This technical progress underpins a clear, near-term commercialization strategy focused on generating revenue from two sources: the sale of radioisotopes and rental income from its planned FusionWERX testing facility. The facility's construction is supported by a $10 million grant from Washington State, contingent on a 50% cost-match from the company. Consequently, Avalanche is reportedly raising a Series A round, framing the fundraise as a critical step to unlock non-dilutive state funding. Management has provided concrete financial targets, forecasting profitability by 2028 and revenues between $30 million and $50 million by 2029, offering tangible metrics for valuation in a sector often defined by long-term, speculative timelines.

Key Decisions for Investors

• Venture capital investors should evaluate the upcoming Series A round as a primary entry point, noting that its immediate purpose is to unlock a $10 million state grant, providing significant leverage on new capital.
• Investors should recognize that the dual-revenue model, based on radioisotope sales and facility rentals, offers a de-risked pathway to projected 2028 profitability that is not solely dependent on achieving net-energy-gain fusion.
• For those monitoring the broader energy transition space, key validation milestones to track will be the successful completion of the Series A, the subsequent construction of the FusionWERX facility, and initial revenue generation, which will test the viability of the 2029 revenue projections of $30-50 million.